New, Robust and Inexpensive Technique for Protein Analysis in Tissues

A new technique to study proteins, which does not require advanced equipment, specialized labs or expensive reagents, has been developed at Uppsala University, Sweden. The technique could be further developed to be used in point of care devices, for instance for diagnostic purposes. The possibility to identify and localize proteins in tissues is essential for understanding disease mechanisms and for diagnostics. However, today very advanced instruments are often needed to study proteins and how they interact with each other. An example is the microscopy technique that was awarded last year's Nobel Prize in chemistry; super resolution fluorescence microscopy.

Such equipment is expensive to purchase and often requires special training to handle. In order to use protein detection for diagnostic purposes, e.g. in a clinic, new, less complicated methods to study proteins are needed. Such methods should be temperature insensitive and not require expensive instruments, costly reagents or specially trained staff.

In the most recent issue of the journal Nature Communications the researchers present a technique that could be used by for instance hospital staff, to detect relevant proteins. The technique is based on the binding of antibodies, either to two sites on the same protein or to two proteins that are localized very close to each other. The antibodies have been linked to DNA strands that will attach to each other if they are close enough. When this happens a chain reaction will start in which increasing numbers of DNA strands are attached. To each DNA strand a fluorescent substance has been linked, which will emit light when it is irradiated with light of a certain wavelength.

"When the chain reaction has run for a while enough fluorescent molecules have been incorporated to allow us to observe them as very bright dots in a microscope, reflecting the presence of a protein of interest. The more dots there more protein," says Ola Söderberg, who has developed the technique together with Masood Kamali-Mogaddam and their research teams.

The chain reaction does not include any enzymes, which means that it can take place at room temperature. The microscopes needed to study the bright dots are relatively simple and commonly available in hospital and research labs. Since two antibodies are bound in the first step "false" signals can be avoided, making the reaction very specific for the studied protein.

"All this implies that our technique can be used as a robust and inexpensive method to localize proteins in tissues. We hope that it soon can be used both for clinical applications and for research purposes," says Ola Söderberg.

The technique has been developed in collaboration with researchers in Uppsala, Scotland and Austria. The results have been published online in the journal Nature Communications.

Reference: Proximity Dependent Initiation of Hybridization Chain Reaction, Nature Communications, DOI: 10.1038/ncomms8294

Science for Life Laboratory (SciLifeLab) is a national centre for molecular biosciences with the focus on health and environmental research. The centre combines advanced technical know-how and state-of-the art equipment with a broad knowledge of translational medicine and molecular bioscience.

Uppsala University - quality, knowledge, and creativity since 1477 World-class research and outstanding education of global benefit to society, business, and culture. Uppsala University is one of northern Europe's highest ranked academic institutions.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...